BioInvent International AB Strategic Asset Allocation Index
BioInvent International AB strategic asset allocation index. BioInvent International AB (BINV) has a Strategic Asset Allocation Index of 5.2% as of December 2024. Strategic assets (PP&E of Skr46.02 Million plus long-term investments of Skr-) total Skr46.02 Million, measured against net assets of Skr885.82 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. Check BioInvent International AB tangible book value ratio to evaluate the tangible quality of the company's equity base.
SAAI
Strategic Assets
PP&E
Net Assets
Strategic Asset Allocation Index of BioInvent International AB (2000–2024)
Strategic asset allocation index of BioInvent International AB from 2000 to 2024. This chart shows how BioInvent International AB's Strategic Asset Allocation Index has evolved across 25 annual periods from 2000 to 2024. As of December 2024, the index stands at 5.2%, representing strategic assets of Skr46.02 Million against net assets of Skr885.82 Million SEK.
BioInvent International AB Strategic Asset Allocation Index by Year (2000–2024)
BioInvent International AB strategic asset allocation index by year from 2000 to 2024. The table below presents the year-by-year Strategic Asset Allocation Index for BioInvent International AB from 2000 to 2024, covering 25 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see market value of BioInvent International AB.
| Year | SAAI | Strategic Assets (SEK) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2024 | 5.2% | Skr46.02 Million | Skr46.02 Million | Skr- | Skr885.82 Million | ▲ +1.2 pp |
| 2023 | 4.0% | Skr52.66 Million | Skr52.66 Million | Skr- | Skr1.31 Billion | ▲ +0.8 pp |
| 2022 | 3.2% | Skr52.01 Million | Skr52.01 Million | Skr- | Skr1.61 Billion | ▼ -0.4 pp |
| 2021 | 3.6% | Skr49.08 Million | Skr49.08 Million | Skr- | Skr1.37 Billion | ▼ -0.4 pp |
| 2020 | 4.0% | Skr29.60 Million | Skr29.60 Million | Skr- | Skr743.50 Million | ▼ -15.5 pp |
| 2019 | 19.5% | Skr33.01 Million | Skr33.01 Million | Skr- | Skr169.44 Million | ▼ -1.1 pp |
| 2018 | 20.6% | Skr18.03 Million | Skr18.03 Million | Skr- | Skr87.62 Million | ▲ +5.8 pp |
| 2017 | 14.8% | Skr19.25 Million | Skr19.25 Million | Skr- | Skr130.22 Million | ▲ +12.3 pp |
| 2016 | 2.5% | Skr5.65 Million | Skr5.65 Million | Skr- | Skr230.44 Million | ▼ -2.0 pp |
| 2015 | 4.5% | Skr1.32 Million | Skr1.32 Million | Skr- | Skr29.45 Million | ▲ +0.1 pp |
| 2014 | 4.4% | Skr2.30 Million | Skr2.30 Million | Skr- | Skr52.43 Million | ▼ -3.6 pp |
| 2013 | 8.0% | Skr3.93 Million | Skr3.93 Million | Skr- | Skr49.01 Million | ▼ -6.2 pp |
| 2012 | 14.2% | Skr6.78 Million | Skr6.78 Million | Skr- | Skr47.62 Million | ▲ +6.3 pp |
| 2011 | 8.0% | Skr11.01 Million | Skr11.01 Million | Skr- | Skr137.95 Million | ▼ -7.1 pp |
| 2010 | 15.1% | Skr11.20 Million | Skr11.20 Million | Skr- | Skr74.19 Million | ▼ -6.4 pp |
| 2009 | 21.5% | Skr11.97 Million | Skr11.97 Million | Skr- | Skr55.63 Million | ▲ +14.4 pp |
| 2008 | 7.1% | Skr16.43 Million | Skr16.43 Million | Skr- | Skr231.30 Million | ▲ +1.4 pp |
| 2007 | 5.7% | Skr12.28 Million | Skr12.28 Million | Skr- | Skr214.12 Million | ▼ -6.5 pp |
| 2006 | 12.2% | Skr13.44 Million | Skr13.44 Million | Skr- | Skr110.15 Million | ▲ +7.0 pp |
| 2005 | 5.2% | Skr11.39 Million | Skr11.39 Million | Skr- | Skr219.00 Million | ▼ -5.3 pp |
| 2004 | 10.6% | Skr22.44 Million | Skr22.44 Million | Skr- | Skr212.68 Million | ▼ -0.8 pp |
| 2003 | 11.3% | Skr34.55 Million | Skr34.55 Million | Skr- | Skr304.96 Million | ▲ +0.2 pp |
| 2002 | 11.1% | Skr43.82 Million | Skr43.82 Million | Skr- | Skr394.25 Million | ▲ +0.7 pp |
| 2001 | 10.4% | Skr40.51 Million | Skr40.51 Million | Skr- | Skr388.42 Million | ▼ -3.8 pp |
| 2000 | 14.2% | Skr22.74 Million | Skr22.74 Million | Skr- | Skr159.63 Million | — |